Sinphar Pharmaceutical Co. Ltd. (1734.TW) TAI
Currency In TWD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In TWD
| Market Cap | 5.31B |
| Enterprise Value | 5.95B |
| P/E Ratio | 17.57 |
| PEG Ratio | 2.15 |
| Price/Sales Ratio | 1.9 |
| Price/Book Ratio | 1.77 |
| Enterprise/Revenue | 2.06 |
| Enterprise/EBITDA | 10.36 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.1 |
| Operating Margin | 0.12 |
| Return On Assets | 0.05 |
| Return On Equity | 0.1 |
| Revenue | 3.37B |
| Revenue/Share | 18.38 |
| Gross Profit | 1.46B |
| EBITDA | 689.7M |
| Net Income | 365.75M |
| Diluted EPS | 1.92 |
| Total Cash | 1.6B |
| Total Cash/Share | 8.5 |
| Total Debt | 2.05B |
| Total Debt/Equity | 0.59 |
| Current Ratio | 2.04 |
| Book Value Per Share | 19.82 |
| 52-Week Change | 12.5 |
| 52-Week High | 32.59 |
| 52-Week Low | 28.11 |
| Moving Average 50 Days | 31.18 |
| Moving Average 200 Days | 29.67 |
| Average Volume | 404,586 |
| Shares Outstanding | 201.61M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 1 |
| Trailing Annual Dividend Yield | 3.08 |
| Payout Ratio | 0.52 |
| Last Split Factor | 53:50 |
| Last Split Date | August 27, 2026 |